MDM2 amplification in malignant Brenner tumors may play a role in progression to malignancy and aid in separation from urothelial and other ovarian carcinomas-Reference-Cited by-同舟云学术

MDM2 amplification in malignant Brenner tumors may play a role in progression to malignancy and aid in separation from urothelial and other ovarian carcinomas

Published:2021-11 Issue: Volume:117 Page:42-50
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Shetty Sindhu,Habeeb Omar^ORCID,Rivera Christine^ORCID,Astbury Caroline,Przybycin Christopher^ORCID,Joehlin-Price Amy S.

Funder

Cleveland Clinic

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference34 articles.

1. Relative frequency of primary ovarian neoplasms: a 10-year review;Koonings;Obstet Gynecol,1989

2. Borderline and malignant Brenner tumours of the ovary;Hallgrimsson;Acta Pathol Microbiol Scand,1972

3. Proliferative and malignant Brenner tumors of the ovary;Miles;Cancer,1972

4. Tumours of the ovary;Cheung,2020

5. MDM2 promotes the rapid degradation of p53;Haupt;Nature,1997

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Malignant Brenner tumor of the ovary: Pathologic evaluation, molecular insights and clinical management;Human Pathology Reports;2024-06

2. Ovarian Brenner Tumors and Other Rare Ovarian Tumors;Gynecologic and Obstetric Pathology;2024

3. Advances in diagnosis, clinical management and molecular characterization of ovarian Brenner tumors;Gynecology and Obstetrics Clinical Medicine;2023-03

4. Coexistence of malignant ovarian Brenner tumor and borderline mucinous cystadenoma, combined with primary uterine corpus endometrioid carcinoma: A case report and literature review;Oncology Letters;2022-06-22